$10 Million GTD Venom tourney
SUMMER CONTINUES TO SIZZLE AT ACR WITH THE RETURN OF $10 MILLION VENOM
Poker players who like big action on the felt 12 months a year are flocking to ACR Poker. That’s because their tables continue to sizzle all summer, with the latest news being the return of their $10 Million GTD Venom tourney.
“Last summer our Venom had a $10,042,500 prize pool and we’re looking for another huge turnout again this time,” stated Chris Moneymaker, ACR Pro. “And remember, the winner this year will walk away with at least $1,000,000.”
The $10 Million GTD Venom starts on Thursday, July 20th with the first of five Day 1 options. Day 2 will be on Monday, July 31st, Day 2 on Tuesday, August 1st and then the climatic final table on Wednesday, August 2nd.
The Venom direct buy-in is $2,650. However, players can get their seat for just pennies through Venom Blitz Satellites and Step tourneys. There are also hundreds of seats available for cheap through the Venom Fever satellite extravaganza.
Moneymaker went on to note that there are huge plans in the works at ACR for the rest of the summer, and while details can’t be released yet, it will surely blow players’ minds.
For more information on the $10 Million GTD Venom, visit ACRPoker .eu.
-
Balkans7 days ago
EGT Digital’s iGaming platform X-Nave and successful titles to deliver high-quality experience to BetHub’s customers
-
Bragg7 days ago
Bragg Gaming Group Announces Record Third Quarter 2024 Revenue of Eur 26.2 Million (USD 29.3 Million)
-
Amusnet7 days ago
Amusnet Joins GAT Caribe Cancún to Showcase Gaming Excellence
-
Compliance Updates7 days ago
Massachusetts Gaming Commission Launches Official Seal of Approval
-
Australia7 days ago
ACMA: Tabcorp Pays $262,000 Penalty for Illegal In-Play Bets
-
Latest News7 days ago
Week 46/2024 slot games releases
-
Africa4 days ago
South Africa: Tribunal Grants Lottoland Interim Relief – Orders Google to Grant Lottoland Access to its Advertising Platform
-
Latest News7 days ago
The MGA publishes its 2023 Annual Report and Financial Statements